* Neuronetics Inc STIM.OQ STIM.O is expected to show a
fall in
quarterly revenue when it reports results on February 10
(estimated) for the period ending December 31 2024
* The Malvern Pennsylvania-based company is expected to
report a
3.3% decrease in revenue to $19.634 million from $20.31 million
a year ago, according to the mean estimate from 4 analysts,
based on LSEG data.The company's guidance on November 12 2024,
for the period ended December 31, was for revenue between $19.00
million and $20.00 million.
* LSEG's mean analyst estimate for Neuronetics Inc is for a
loss
of 25 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Neuronetics
Inc
is $3.00, below its last closing price of $3.56.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2024 -0.23 -0.23 -0.44 Missed -91.3
Jun. 30 2024 -0.27 -0.27 -0.33 Missed -22.2
Mar. 31 2024 -0.32 -0.31 -0.27 Beat 12.9
Dec. 31 2023 -0.26 -0.26 -0.19 Beat 27.3
Sep. -0.31 -0.31 -0.33 Missed -6.7
30 2023
Jun. 30 2023 -0.35 -0.35 -0.17 Beat 51.2
Mar. 31 2023 -0.39 -0.39 -0.38 Beat 2.1
Dec. 31 2022 -0.35 -0.38 -0.30 Beat 21.3
This summary was machine generated February 7 at 14:31 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)